Revolutionary type 2 diabetes pill introduced in Saudi Arabia

Revolutionary type 2 diabetes pill introduced in Saudi Arabia

In Saudi Arabia, one in five people are diagnosed with the chronic progressive disease type 2 diabetes. This figure is double the global rate, meaning that the disease represents a serious public health issue for the Kingdom. If ignored, the disease can cause serious medical complications. The usual treatment for controlling blood sugar is regular insulin injections. Leading global health company Novo Nordisk recently launched the oral medicine to control blood sugar for type 2 diabetes patients. It is now used in the Kingdom and across the Arab world. The announcement was presented in a press conference in Jeddah with the presence of elite international and local endocrinologists, family medicine consultants, and health specialists. The pill, GLP-1 RA, is certified by the Saudi Food and Drug Authority. The importance of this revolutionary treatment lies in its pill form. Medical director and quality manager of Novo Nordisk, Motaz Yahya, told Arab News: “The treatment of GLP-1 RA has been there in the market a long time ago in injection form, but our team created this innovative pill to help patients with diabetes to have a normal lifestyle.” HIGHLIGHTS • The Kingdom approves pill form GLP-1 RA type 2 diabetes medication. •